Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesA case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
Journal of Cutaneous Pathology, 06/11/09
Pongpudpunth M et al. - In the United States, select EGFRIs have been approved in certain patients with non-small cell lung cancer, metastatic colorectal carcinoma, and advanced squamous cell carcinoma of the head and neck. Various cutaneous side effects of EGFRIs have been reported, including acneiform eruptions, chronic paronychia, xerosis, a seborrheic dermatitis-like eruption, changes in hair texture, and nonscarring alopecia.
Related Articles
Epithelial–mesenchymal transition in ovarian cancer
Cancer Letters, 11/05/09
Relevance Score: 82%
Epidermal growth factor receptor tyrosine kinase inhibitors: similar but different
Anti-Cancer Drugs, 10/19/09
Relevance Score: 81%
Vasoactive intestinal peptide and inflammatory cytokines enhance vascular endothelial growth factor production from epidermal keratinocytes
British Journal of Dermatology, 10/05/09
Relevance Score: 81%
The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure
Experimental and Clinical Cardiology, 11/16/09
Relevance Score: 80%
Expression of Nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues
Journal of Cancer Research & Clinical Oncology, 10/23/09
Relevance Score: 80%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer
Cancer, 11/30/09
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
The Lancet Oncology - Online First, 11/30/09
Multimodal preoperative evaluation system in surgical decision making for rectal cancer: a randomized controlled trial
International Journal of Colorectal Disease, 11/30/09
Sponsor
Article Search
Sponsor